The following is a summary of "Diagnostic performance of contrast-enhanced CT combined with contrast-enhanced MRI for ...

Liver fat (PDFF) and disease activity (cT1) were used to identify patients not requiring biopsy in the imaging arm. Key findings of the RADIcAL-1 study showed: The use of non-invasive multiparametric ...

Liver cancer, predominantly hepatocellular carcinoma (HCC), remains one of the most aggressive and leading causes of ...

An AI algorithm demonstrated strong performance for detecting chronic liver disease from routinely acquired echocardiography ...

Liver fat (PDFF) and disease activity (cT1) were used to identify patients not requiring biopsy in the imaging arm. Key findings of the RADIcAL-1 study showed: The use of non-invasive ...

PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny ...

Recent advancements in liver imaging, particularly the use of hepatocyte-specific contrast agents, have enhanced the ...

This candidate also demonstrated reductions from baseline in clinically relevant biomarkers, including those measuring liver fat (MRI-PDFF) and insulin resistance (HOMA-IR), inflammation (ALT ...